Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment

BACKGROUND: It has previously been shown that bevacizumab, when added to chemotherapy, improved overall survival in several cancers. In glioblastoma multiforme (GBM), bevacizumab increased progression-free survival and it is widely used for tumor recurrence, though it has failed to improve overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chiung-Chyi, Cheng, Wen-Yu, Lee, Chung-Hsin, Dai, Xue-Jun, Chiao, Ming-Tsang, Liang, Yea-Jiuen, Hsieh, Wan-Yu, Mao, Tsuo-Fei, Lin, Guo-Shi, Chen, Shou-Ren, Liu, Bai-Shuan, Chen, Jun-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391574/
https://www.ncbi.nlm.nih.gov/pubmed/32727419
http://dx.doi.org/10.1186/s12885-020-07210-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391574/
https://www.ncbi.nlm.nih.gov/pubmed/32727419
http://dx.doi.org/10.1186/s12885-020-07210-8

Ejemplares similares